TVARDI THERAPEUTICS INC

TVRD · NASDAQ

Updated at 2026-10-21 16:51:52

$1.08+8.87%
Today's High
$1.09
Today’s Low
$1.02
TVARDI THERAPEUTICS INC (TVRD) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.03
Previous Close
$0.99
Volume
195.18K
Market Cap
$13.23M
P/E Ratio
--
EPS
$-2.77

Previous Day Range

$0.97$1.07

52-Week Range

$0.93$6.65

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
3 SUGAR CREEK CENTER BOULEVARD, SUGAR LAND, TX, UNITED STATES, 77478
Country
US
Listing Date
2014-01-31
Fiscal Year End
December
Shares Outstanding
12.49M
CIK
0001346830

Tvardi Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing novel oncology therapies to meet critical unmet medical needs. Leveraging its proprietary drug discovery platform, Tvardi specializes in small molecule therapies designed to target protein degradation pathways, enhancing the effectiveness of cancer treatments. Its lead candidate, TVB-2640, is engineered to disrupt cancer cell survival mechanisms, reflecting the company's commitment to offering transformative therapeutic options. With a robust pipeline and a strong emphasis on scientific excellence, Tvardi is well-positioned to significantly influence the future of cancer treatment.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$6.62M

2026-03-31

$7.05M

2025-12-31

$7.58M

2025-09-30

$5.93M

Net Income

2026-06-30

-$6.45M

2026-03-31

-$6.8M

2025-12-31

-$7.27M

2025-09-30

-$5.52M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.69

2026-03-31

$-0.73

2025-12-31

$-0.78

2025-09-30

$-0.59

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$6.6M

2026-03-31

-$6.78M

2025-12-31

-$7.25M

2025-09-30

-$5.5M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.